Your browser doesn't support javascript.
loading
AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting.
Faivre, J C; Tomaszewski, F; Demoor-Goldschmitt, C; Beddok, A; Malgras, A; Schmitt, A; Fabre, J; Perrot, A; Jovenin, N; Salleron, J; Clavère, P; Pointreau, Y; Scotté, F; Bensadoun, R J; Block, V; Thariat, J.
Afiliación
  • Faivre JC; Lorraine Cancer Institute, Department of radiation therapy, F-54500 Vandœuvre-lès-Nancy, France. Electronic address: jeanchristophe.faivre@gmail.com.
  • Tomaszewski F; Jean Godinot Institute, Department of radiation therapy, F-51100 Reims, France; Lorraine Cancer Institute, F-54500 Vandoeuvre-Lès-Nancy, France.
  • Demoor-Goldschmitt C; West Cancer Institute, Department of Radiation Therapy, F-44800 Saint-Herblain, France.
  • Beddok A; Centre de Protonthérapie, Institut Curie, F-91400 Orsay, France.
  • Malgras A; Nancy Regional and University Hospital, Nutrition Department, F-54035 Nancy, France.
  • Schmitt A; Lorraine Cancer Institute, dietician, F-54500 Vandoeuvre-lès-Nancy, France.
  • Fabre J; Troyes Hospital Center, Department of Radiation Therapy, F-10000 Troyes, France.
  • Perrot A; Toulouse University of Cancer Oncopole, Hematology, F-31100 Toulouse, France.
  • Jovenin N; Polyclinic of Courlancy, Department of Medical Oncology, F-51100 Reims, France.
  • Salleron J; Lorraine Cancer Institute, data management - biostatistics, F-54500 Vandoeuvre-lès-Nancy, France.
  • Clavère P; Limoges University Hospital Center, Department of radiation therapy, F-87000 Limoges, France.
  • Pointreau Y; Jean Bernard center, Department of radiation therapy, F-72100 Le Mans, France.
  • Scotté F; Gustave Roussy institute, department of medical oncology, F-94805 Villejuif, France.
  • Bensadoun RJ; French Riviera Cancer Center, Department of radiation therapy, F-06250 Mougins, France.
  • Block V; Home hospitalisation in Nancy conurbation, pharmacy, F-54500 Vandoeuvre-lès-Nancy, France.
  • Thariat J; Department of Radiation Therapy / ARCHADE, François Baclesse center14000 Caen, France.
Crit Rev Oncol Hematol ; 180: 103825, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36223807
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antieméticos / Antineoplásicos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antieméticos / Antineoplásicos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article